Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Teromab AB
AB
Active
Org 5569149114
Herrestads Lanesund 130, 451 98
Uddevalla
Activities of holding companies
·
NACE 6421
Est. 2012 · 13 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Activities of holding companies
/
Teromab AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
152
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−29
114
−10
−3
−1
Depreciation & amort.
−0
−0
—
—
—
EBIT
−29
114
−10
−3
−1
Net financials
−10 273
−9
—
−0
−1 000
Profit before tax
−4 551
79
45
−3
998
Tax
−0
−17
−10
—
−0
Net profit
−4 551
62
35
−3
998
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
124
514
490
490
1 258
Equity
−231
51
86
82
1 080
Long-term debt
67
0
—
—
—
Short-term debt
111
259
255
258
29
Total debt
178
259
255
258
29
Financial ratios
5-year trend
EBITDA margin
-135100.0%
This company
15.8%
Market median
-855163% vs market
2020
2024
Equity ratio
85.8%
This company
38.2%
Market median
+125% vs market
2020
2024
Return on equity
92.4%
This company
18.4%
Market median
+402% vs market
2020
2024
Net profit margin
99774800.0%
This company
8.1%
Market median
+1231787554% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Teromab AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
